Supriya Lifescience
Verified Launch date
Market cap
-
Net debt
-
Enterprise valuation
$420m (Public information from Jun 2024)
Share price
INR387.60001 SUPRIYA.NS
Mumbai Maharashtra (HQ)
| INR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 24 % | 35 % | (11 %) | 22 % | 22 % | 22 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 35 % | 46 % | 42 % | 30 % | 29 % | 29 % | 29 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 24 % | 32 % | 29 % | 19 % | 20 % | 22 % | 22 % |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor investor | $0.0 | round | |
* | N/A | $92.0m | IPO |
| Total Funding | 000k | ||